EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL



RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL



American Journal of Kidney Diseases 62(5): 919-928



Changes in anemia management over the past decade have produced downward shifts in hemoglobin concentrations. We aimed to examine the effect on use of red blood cell (RBC) transfusions. Retrospective cohort study. We identified point prevalent Medicare hemodialysis patients as of January 1 of each year (1999-2010) and categorized them based on 3-month (April to June) mean hemoglobin levels (<10 or ≥10 g/dL) in each year. Hemoglobin patterns over time and clinical profiles based on achieved hemoglobin concentrations. RBC transfusion use. We used negative binomial modeling to examine the effect of hemoglobin level <10 g/dL on transfusion use, adjusting for case-mix differences. Proportions of patients with mean hemoglobin levels <10 g/dL decreased from 10% (1999) to ~4% (2005), but began increasing after 2006 and reached 6% by 2010. Accounting for case-mix differences, transfusion rates remained relatively constant at approximately 7.9 per 100 person-months for patients with hemoglobin levels <10 g/dL and 2 per 100 person-months for patients with hemoglobin levels ≥10 g/dL. Patients with average hemoglobin levels <10 g/dL were more likely to receive transfusions (risk ratio, 2.2; 95% CI, 2.1-2.2) even after adjustment; the risk ratio doubled if hemoglobin levels remained <10 g/dL for 6 months (4.4; 95% CI, 3.7-5.2). Limited in generalizability to patients with Medicare as primary payer; residual confounding from factors such as frailty and chronic inflammation cannot be excluded; categorizing patients based on an average of 3 outpatient hemoglobin measurements may introduce some misclassification. Risk of transfusion increases substantially with hemoglobin concentrations <10 g/dL; risk appears to be independent of other clinical factors. If anemia management patterns shift toward lower hemoglobin concentrations, RBC transfusion use likely will increase in dialysis patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333602

Download citation: RISBibTeXText

PMID: 23815986

DOI: 10.1053/j.ajkd.2013.05.004



Related references

Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy. Clinical Journal of the American Society of Nephrology 3(6): 1669-1675, 2008

Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients. American Journal of Kidney Diseases 62(5): 947-952, 2014

Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002. Hemodialysis International. International Symposium on Home Hemodialysis 11(3): 333-339, 2007

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy results of a retrospective study of 386 patients. International Journal of Radiation Oncology, Biology, Physics 16(1): 37-42, 1989

The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study. Clinical Journal of the American Society of Nephrology 7(1): 52-59, 2012

Elevated total serum leptin levels in hemodialysis patients are due to an increase in free but not bound leptin concentrations Influence of high and low flux hemodialysis. Kidney & Blood Pressure Research 23(3-5): 308, 2000

Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. American Journal of Kidney Diseases 40(3): 549-555, 2002

Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Internal Medicine 37(10): 826-830, 1998

The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis. Medical Archives 67(5): 361-364, 2014

Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: comparison between the hemodialysis and non-hemodialysis days. Therapeutic Apheresis and Dialysis 11(4): 288-295, 2007

Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients. Vojnosanitetski Pregled 68(9): 749-755, 2011

Serum leptin concentrations in hemodialysis patients Influence of the dialyser. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 90A, Sept, 1999

Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 36(8): 2286-2293, 2014

Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia. Journal of the Medical Association of Thailand 90(12): 2574-2586, 2007

Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia. Journal of the Medical Association of Thailand 90(12): 2574-2586, 2008